Drug-Associated Acute Kidney Disease: Data From a World Pharmacovigilance Database

Europe Acts to Address GLP-1 Drug Shortages

Recomendaciones para prescripción segura de opioides y otros fármacos para dolor en el tratamiento de dolor agudo en hospitalización

Adverse Drug Reactions in Multi-Drug Resistant Tuberculosis Patients, in India, who had received DOTS Plus Treatment along with Home Care and Counselling

Blockchain and AI in Pharmaceutical Supply Chain

Notificación de sospechas de medicamentos falsificados

Acetaminophen Use During Pregnancy—Reply

Acetaminophen Use During Pregnancy

How regulation can help to unlock the potential of preventative medicines

Olanzapine and Benzodiazepine Safe in Agitated ED Patients

Impacto da atuação do Programa de Farmacovigilância nas notificações de reações adversas a medicamentos antineoplásicos em um hospital universitário

A Systematic Review of Healthcare Providers Awareness of Medication Switching for Polypharmacy Patients in Saudi Arabia

Medicina de Precisión en diabetes mellitus tipo 1

Severity and Risk Rating of Drug-Drug Interaction Potency in Chronic Kidney Disease in Public Health Hospital

Top 10 Signs and Symptoms of Psychotropic Adverse Drug Events to Monitor in Long-Term Care Residents

Optimizing drug therapy for older adults: shifting away from problematic polypharmacy

Myocarditis associated with COVID-19 vaccination

Artificial Intelligence Can Be Regulated Using Current Patient Safety Procedures and Infrastructure in Hospitals

Adverse events during intravenous fosfomycin therapy in a real-life scenario. Risk factors and the potential role of therapeutic drug monitoring

Man who illegally imported unlicensed medicines from India, the Middle East and the Far East sentenced

EMA recommends revoking conditional marketing authorisation for Ocaliva

EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna

El trabajo multidisciplinario en la farmacovigilancia

How could employing the patient perspective transform pharmacovigilance?

“If everyone knew about this, how many lives could we save?”: Do drug suppliers have a role in reducing overdose risk?

Teaching gender medicine can enhance the quality of healthcare

Sexual Dysfunction Induced by Antidepressants—A Pharmacovigilance Study Using Data from VigiBaseTM

El Colegio de Farmacéuticos celebró el fallo judicial que suspendió el expendio de medicamentos de venta libre fuera de las farmacias

Comparison of Infection Risks Between Various Inhaled and Intranasal Corticosteroids: A Pharmacovigilance Analysis Based on the FAERS Database

Healthcare professionals' willingness to utilize a mobile health application for adverse drug reaction reporting in a limited resource setting: an input for digital health, 2023

Trends in the availability and prices of quality-assured tuberculosis drugs: a systematic analysis of Global Drug Facility Product Catalogs from 2001 to 2024

Evaluation of nurses’ attitudes and behaviors regarding narcotic drug safety and addiction: a descriptive cross-sectional study

Targeted Delivery Strategies for Multiple Myeloma and Their Adverse Drug Reactions

Safety evaluation of bempedoic acid: A pharmacovigilance analysis using FDA adverse event reporting system data

Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs

Real-World Data-Derived Pharmacovigilance on Drug-Induced Cognitive Impairment Utilizing a Nationwide Spontaneous Adverse Reporting System

Immunosuppressives Unlikely to Raise Cancer Risk in IBD Patients With Prior Cancer

The Role of the Drug and Food Control Agency (BPOM) in Addressing the Distribution of Illegal Cosmetics

The Latest Quantum and Medical, Quantum and Pharmaceutical Technologies in Countering the Criminal and Legal, Forensic and Pharmaceutical Risks of Circulation of Falsified Drugs

Leveraging the Efficiency in Supply Chain Mechanism for Enabling the Optimized Distribution in Drug Serialization